Skip to Content
Merck
  • Development of multi-walled carbon nanotubes reinforced monetite bionanocomposite cements for orthopedic applications.

Development of multi-walled carbon nanotubes reinforced monetite bionanocomposite cements for orthopedic applications.

Materials science & engineering. C, Materials for biological applications (2013-08-06)
Nariman Mansoori Boroujeni, Huan Zhou, Timothy J F Luchini, Sarit B Bhaduri
ABSTRACT

In this study, we present results of our research on biodegradable monetite (DCPA, CaHPO4) cement with surface-modified multi-walled carbon nanotubes (mMWCNTs) as potential bone defect repair material. The cement pastes showed desirable handling properties and possessed a suitable setting time for use in surgical setting. The incorporation of mMWCNTs shortened the setting time of DCPA and increased the compressive strength of DCPA cement from 11.09±1.85 MPa to 21.56±2.47 MPa. The cytocompatibility of the materials was investigated in vitro using the preosteoblast cell line MC3T3-E1. An increase of cell numbers was observed on both DCPA and DCPA-mMWCNTs. Scanning electron microscopy (SEM) results also revealed an obvious cell growth on the surface of the cements. Based on these results, DCPA-mMWCNTs composite cements can be considered as potential bone defect repair materials.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydroxyapatite, Type I, buffered aqueous suspension
Sigma-Aldrich
Calcium phosphate dibasic, 98.0-105.0%
Sigma-Aldrich
Dibasic Calcium Phosphate, meets USP testing specifications
Sigma-Aldrich
Hydroxyapatite, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
Sigma-Aldrich
Hydroxyapatite, purum p.a., ≥90% (as Ca3(PO4)2, KT)